Google News – Clinical Trials External News
Clinical Research & CRO Articles
Google News – Clinical Trials External News
ERS 2026: tozorakimab’s groundbreaking exacerbation reduction sets a new bar in COPD - Clinical Trials Arena
Google News – Pharmaceuticals External News
What’s in a List? EPA Eyes PFAS, Pharmaceuticals and Microplastics in Drinking Water - Williams Mullen
Google News – Clinical Trials External News
PhenoNet, Inc. Completes Recruitment and Randomization in Phase IIb Clinical Trial Evaluating PHENOGENE-1A for Amyotrophic Lateral Sclerosis (ALS) - BioSpace
Google News – Clinical Trials External News
Trialbee to Present with Takeda, Showcase AI for Clinical Sites, and Unveil AI-Powered Patient Screening at DPHARM 2026 - BioSpace
Google News – Clinical Trials External News
Massive Bio and PrecisCa Announce Strategic Partnership to Expand Cancer Patient Access to Clinical Trials Across the U.S. - AOL.com
Google News – Clinical Trials External News
Massive Bio and PrecisCa Announce Strategic Partnership to Expand Cancer Patient Access to Clinical Trials Across the U.S. - New Castle News
Google News – Clinical Trials External News
DYNAMIKA™: The Operating System for Imaging Clinical Trials - The Clinical Trial Vanguard
Google News – Clinical Trials External News
AEYE-DS Clinical Trials Published: First Fully Autonomous Diabetic Retinopathy Screening Technology Across Portable and Tabletop Devices Demonstrates 99% Imageability, One-Image-per-Eye Workflow, and Best-in-Class Diagnostic Efficacy - PR Newswire
Google News – Biopharma External News
Quantum BioPharma receives FDA clearance for MS phase 2 trial By Investing.com - Investing.com India
Google News – Clinical Trials External News
Trialbee to Present with Takeda, Showcase AI for Clinical Sites, and Unveil AI-Powered Patient Screening at DPHARM 2026 - Business Wire
Google News – Biopharma External News
Propanc Biopharma plans phase 1b cancer trial in Australia - Investing.com
Google News – Biopharma External News
Quantum BioPharma Ltd. Secures FDA Clearance to Begin Phase 2 Trial of Lucid-MS for Multiple Sclerosis - Quiver Quantitative
Google News – Biopharma External News
Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment - Yahoo! Finance Canada
Google News – Biopharma External News